Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Quality of reported income
3Y CAGR
+33.2%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.75 | +8.4% |
| 2023 | 0.69 | -21.1% |
| 2022 | 0.88 | +176.2% |
| 2021 | 0.32 | +17.9% |
| 2020 | 0.27 | - |
| 2019 | 0.00 | - |